Body composition metrics as a determinant of trastuzumab deruxtecan related toxicity and response.
Saved in:
| Title: | Body composition metrics as a determinant of trastuzumab deruxtecan related toxicity and response. |
|---|---|
| Authors: | Yaacobi Peretz S; Oncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Kessner R; Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Radiology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Bar Y; Oncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Sonnenblick A; Oncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel., Lerner S; Oncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Deutsch-Lukatsky A; Oncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Popuri K; Computer Science Department, Memorial University of Newfoundland, St. John's, NL, Canada., Beg MF; School of Engineering Science, Simon Fraser University, Burnaby, BC, Canada., Shachar SS; Oncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Shlomitss@tlvmc.gov.il.; Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel. Shlomitss@tlvmc.gov.il. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2025 Apr 25; Vol. 11 (1), pp. 38. Date of Electronic Publication: 2025 Apr 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2374-4677 |
|---|---|
| DOI: | 10.1038/s41523-025-00754-7 |
